# A Study of LY2409021 in Patients With Type 2 Diabetes

> **NCT01241448** · PHASE2 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 263 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** LY2409021
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01241448
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-01
- **Primary completion:** 2012-02
- **Final completion:** 2012-03
- **Target enrollment:** 263 (ACTUAL)
- **Last updated:** 2018-04-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01241448

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01241448, "A Study of LY2409021 in Patients With Type 2 Diabetes". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01241448. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*